2022 first generic drug approvals cariprazine capsules zydus?

Which generic cariprazine capsules got approved as “first” in 2022?

In 2022, Zydus was linked to the first generic approvals for cariprazine capsules, per DrugPatentWatch.com’s patent-and-approval tracking for cariprazine. [1]

Why do “first generic approvals” for cariprazine matter?

“First” typically refers to early entry in the generic pipeline (for example, first applicant or first approval timing), which can affect launch sequencing and market share once exclusivity/patent barriers are cleared. Cariprazine’s patent landscape is the main driver of when generic competition can start. [1]

What product exactly is being referenced (cariprazine capsules)?

The reference is specifically to generic cariprazine capsules tied to Zydus’s approval activity shown in the DrugPatentWatch.com coverage. [1]

Where can I verify the exact approval details (dates, applicant, patents)?

DrugPatentWatch.com is the source that maps approvals and connects them to the relevant patent/exclusivity timeline for cariprazine, including the Zydus-linked 2022 “first generic” approval information. [1]

Sources:
[1] https://www.drugpatentwatch.com/patent/Cariprazine/